Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals Inc. in Tarrytown recently announced preliminary, positive safety and efficacy results from the first patient (2 years of age) dosed in the Phase 1/2 Chord trial investigating otoferlin gene therapy (DB-OTO) in children with profound genetic hearing loss due to mutations of the otoferlin gene. “The children who are being enrolled in Chord […]
Operator: Welcome to the Regeneron Pharmaceuticals Third Quarter 2023 Earnings Conference Call. My name is Shannon, and I will be your operator for today s call.